{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-011871","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2024-03-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.231507+00:00","generated_at":"2026-06-04T05:26:07.864899+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ensysce Biosciences receives Nasdaq deficiency notice for bid price below $1.00, given 180 days to comply","bullets":["Received Nasdaq deficiency letter on March 27, 2024 for bid price closing below $1.00 for 30 consecutive business days.","Has until September 23, 2024 to regain compliance by maintaining $1.00 bid price for at least 10 consecutive business days.","Also has prior stockholders' equity non-compliance; Nasdaq Panel granted continued listing until May 13, 2024.","Company will monitor closing bid price and evaluate options, but no assurance of regaining or maintaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-011871","json":"https://secwatch.observer/filing/0001493152-24-011871.json","markdown":"https://secwatch.observer/filing/0001493152-24-011871.md","text":"https://secwatch.observer/filing/0001493152-24-011871.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000149315224011871/0001493152-24-011871-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000149315224011871/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T05:26:07.864899+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"13d62763be10aed0c55b67befbdf4aad91abc9fc","claim":"Ensysce Biosciences, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"March 27, 2024, Ensysce Biosciences Inc. (the “Company”) received a notice (the “Deficiency Letter”) from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the bid price for the Company’s common stock had closed below $1.00 per share for the previous 30 consecutive business days. Nasdaq requires that Ensysce common stock have a minimum bid price of at least $1 per share (the “Minimum Bid Price”). In accordance with Nasdaq listing rule 5810(c)(3)(A), the Company has 180 cal","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315224011871/0001493152-24-011871-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}